What Happened

Jose Llerena, 49, of Miami, Florida, pleaded guilty to conspiracy to distribute a controlled substance for his role as a "patient recruiter" in a conspiracy to distribute over 87,000 oxycodone 30mg pills.

According to court documents and statements made in court, Llerena conspired with others, including Olushola Yusuf, a pharmacist and pharmacy owner convicted at trial earlier in 2026 for illegally dispensing over 300,000 oxycodone 30mg pills. Llerena paid individuals to pose as patients and obtain illegal and unnecessary oxycodone prescriptions from South Florida clinics and doctors. He then took his recruits and their prescriptions to Yusuf's pharmacies to get the pills.

Yusuf kept a list of Llerena's recruits at her pharmacy, and law enforcement seized it. Llerena paid Yusuf cash for the drug at above market value, then paid his recruits, usually via Zelle, before reselling the pills on the street. He was personally responsible for distributing 3,735 oxycodone pills. He faces a maximum penalty of 20 years in prison; a sentencing date has not been set. HHS-OIG, DEA and the FBI investigated the case.

What Went Wrong

The recruiter is not a healthcare worker, but the scheme depended on a pharmacy that would fill what no legitimate pharmacy should:

  • The pharmacy tracked the recruiter's "patients." Keeping a list of one recruiter's people at the pharmacy shows the dispensing was organized around the scheme, not around patient care.
  • Cash above market value. A third party paying cash at inflated prices for oxycodone 30mg is a well-recognized sign of illegitimate dispensing.
  • Groups arriving with one handler. Recruits were brought in by the same person with prescriptions from South Florida clinics and doctors, a pattern a pharmacist exercising corresponding responsibility should question.
  • Prescriptions with no medical need. The recruits posed as patients to obtain unnecessary prescriptions, so the problem began at the prescriber before it reached the pharmacy counter.

How It Could Have Been Prevented

  • Apply corresponding responsibility at every fill and refuse high-strength opioid prescriptions when the circumstances cannot be resolved with the prescriber.
  • Watch for one person accompanying, paying for or coordinating several "patients," and document and escalate it rather than accommodating it.
  • Review cash-pay rates and pricing for oxycodone 30mg; payment well above market value should trigger review, not a sale.
  • Give pharmacy staff a way to report concerns outside the owner's control, such as the state board of pharmacy or DEA.

Related Guidance

Sources